A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis

This study is looking at a nasal spray called monometasone furoate for people with seasonal allergic rhinitis, which is when your nose gets itchy and runny during certain seasons. The study will compare the test spray to a reference spray to see if they are similar in how they work and to check their safety for people with allergies.

• Study Duration: Participants need to be available for multiple visits during the trial.
• Eligibility: Must be aged 18-65 and have a history of moderate to severe seasonal allergies.
• Exclusions: Cannot participate if you have certain medical conditions, recent nasal surgery, or are taking specific medications.

If you join, you'll need to learn how to properly use the nasal spray and keep track of your symptoms. You also need to agree to use birth control if you're a woman. This study is a chance to try a new treatment for your allergies, but it’s important to consider the time commitment and any health requirements before joining. 😊